Claritas Pharmaceuticals
San Rafael
About Claritas Pharmaceuticals
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $31.3M
- Funding stage: IPO
- Last round: Private Equity (Jan 2022)
- Ticker: otcpink:CLAZF
- Website: claritaspharma.com
- Phone: +1 888 861 2008
Industries & Categories
Biotechnology, Cannabis, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/claritas-pharmaceuticals-174924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.